Economic Evaluation of Heart Failure Management in Colombian Clinics (EconoHeart)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01084564 |
Recruitment Status
:
Completed
First Posted
: March 10, 2010
Last Update Posted
: March 10, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Heart Failure Asthma |
Study Type : | Observational |
Actual Enrollment : | 300 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Economic Evaluation of Heart Failure Management in Colombian Clinics |
Study Start Date : | January 2008 |
Actual Primary Completion Date : | June 2008 |
Actual Study Completion Date : | June 2008 |

Group/Cohort |
---|
1
moderate to severe uncontrolled asthma
|
- To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia [ Time Frame: 12 months ]
- Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Asthma moderate to severe.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01084564
Study Director: | Rodolfo Dennis, M.D. | Pontificia Universidad Javeriana | |
Principal Investigator: | MARÍA XIMENA ROJAS, M.D. | Pontificia Universidad Javeriana |
Responsible Party: | MC MD, AstraZeneca |
ClinicalTrials.gov Identifier: | NCT01084564 History of Changes |
Other Study ID Numbers: |
NIS-CCO-ATA-2007/1 |
First Posted: | March 10, 2010 Key Record Dates |
Last Update Posted: | March 10, 2010 |
Last Verified: | March 2010 |
Keywords provided by AstraZeneca:
Cost-effectiveness analysis Colombia |
Additional relevant MeSH terms:
Heart Failure Heart Diseases Cardiovascular Diseases |